Producer
Philips Respironics (Philips Healthcare)
Dutch healthcare technology company (Euronext: PHIA, HQ Amsterdam; ~$18B revenue); Respironics division (acquired from Respironics Inc. 2008) produces mesh nebulizers (InnoSpire Go, SideStream) as part of its respiratory care portfolio. Philips Respironics was severely damaged by the 2021 recall of ~4 million CPAP machines (Continuous Positive Airway Pressure for sleep apnea) due to sound abatement foam that was found to degrade into potentially carcinogenic particles — the largest medical device recall in US history by value (~$1.5B settlement, regulatory sanctions, CEO resignation). The Philips CPAP recall, while unrelated to its nebulizer products, significantly damaged the company's reputation, financial position, and regulatory standing — creating uncertainty about its nebulizer product line continuity. A CPAP foam degradation problem in sleep apnea devices created supply chain uncertainty for mesh nebulizers used by hospital COPD patients.
1
Inputs supplied
1
Goods downstream
0
Facilities
0
Stories
What they make
1 input Philips Respironics (Philips Healthcare) supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something Philips Respironics (Philips Healthcare) makes, pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map, where this supply-chain role fits within their broader business.
Diagnosis & Treatment
45%Connected Care
30%Personal Health
25%
Intelligence
What's known
Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.
Did you know2024
Philips is simultaneously sold in every CVS pharmacy (shavers, oral care, pregnancy tests) and in every hospital supply catalog (CT scanners, ICU ventilators, CPAP machines, nebulizers). The same Dutch brand whose Sonicare toothbrush sits on bathroom counters worldwide also makes the CPAP machine that keeps sleep apnea patients breathing at night and the mesh nebulizer that delivers bronchodilators to COPD patients at home. This consumer-to-clinical span is unusual among major medical device companies — most consumer health brands (Procter & Gamble, Unilever) stopped at over-the-counter products, while most medical device companies (Medtronic, Becton Dickinson) never built consumer retail presence. Philips's respiratory product portfolio specifically (CPAP, nebulizers) straddles both markets: consumer devices sold direct-to-patient and clinical devices sold through hospital systems.
Koninklijke Philips N.V. ↗Incident2021
In June 2021, Philips initiated a voluntary recall of approximately 4 million CPAP (continuous positive airway pressure) and BiPAP machines due to degradation of polyester-based polyurethane foam used for sound abatement — which could release particulates and toxic/carcinogenic gases. This was the largest medical device recall in US history by unit count and one of the largest by financial impact. The recall resulted in: $1.5B settlement with US DOJ, FDA consent decree limiting Philips Healthcare operations, significant revenue and reputational damage, and supply disruption for sleep apnea patients globally who could not receive replacement devices for 1-2 years. While the recall did not directly affect Philips' nebulizer business, the consent decree created regulatory uncertainty across all Philips Healthcare manufacturing — including its respiratory nebulizer product line. The incident illustrates how a component failure in one product category (CPAP foam) can create regulatory overhang that affects an entirely different respiratory product line (mesh nebulizers) from the same company.
FDA ↗Origin2023
Philips was founded in 1891 in Eindhoven by Gerard Philips and his father specifically to manufacture Edison incandescent light bulbs. For its first 50 years it was a lighting company — at one point the world's second-largest light bulb manufacturer. Philips entered electronics (radios, TVs) in the 1920s-30s as a natural extension of its electrical manufacturing base, and healthcare emerged from its medical x-ray lamp business in the 1930s-40s. The acquisition of Respironics in 2008 for $5.1B brought CPAP and respiratory care into Philips alongside imaging, making the Amsterdam-based light bulb company a hospital respiratory device manufacturer — a journey from Edison's invention to hospital ICU ventilators spanning 130 years.
Koninklijke Philips N.V. ↗